A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

NCT06280703 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

118

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Type 1 Diabetes Mellitus

Interventions

DRUG: LY3938577
DRUG: Placebo
DRUG: Insulin Degludec
DRUG: Insulin Lispro
DRUG: LY3938577
DRUG: Placebo
DRUG: Insulin Degludec
DRUG: Basal Insulin
DRUG: Lispro Prandial Insulin

Sponsor

Eli Lilly and Company